14
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Topical and systemic Ofloxacin (Tarivid) in the treatment of Gentamycin-resistant Pseudomonas corneal abscess

, &
Pages 131-134 | Accepted 15 Dec 1992, Published online: 08 Jul 2009

References

  • Borrmann L R, Leopold I H. The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol 1988; 106: 227–228
  • Reidy J J, Hobden J A, Hill J M, Forman K, O'Callaghan R J. The efficacy of topical Ciprofloxacin and Norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1991; 10((1))25–28
  • Borrman L, Tang-Liu D, Kann J, Nista J, Lin E T, Frank F. Ofloxacin in human serum, urine, and tear film after topical application. Cornea 1992; 11((3))226–230
  • Osato M S, Jensen H G, Trousdale M D, Bosso J, Borrmann L R, Frank J, Akers P. The comparative in vitro activity of Ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol 1989; 108: 380–386
  • Mitsui Y, Sakuragi S, Tamura O. Effect of Ofloxacin ophthalmic solution in the treatment of external bacterial infections of the eye. Folia Ophthalmol Jpn 1986; 37: 1115
  • Kumada T, Neu H C. In vitro activity of Ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. J Antimicrob Chemother 1985; 16: 563

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.